To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer Condition: Head and Neck Neoplasms Intervention: Drug: SCB01A Sponsor: SynCore Biotechnology Co., Ltd. Terminated |
Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer Condition: Head and Neck Cancer Intervention: Drug: Panitumumab + paclitaxel Sponsors: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello; Amgen; Trial Form Support S.L. Completed |
The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD) Conditions: Head and Neck Neoplasms; Hearing Loss Intervention: Sponsor: University of Manchester Not yet recruiting |
A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients Condition: Head and Neck Cancer Intervention: Biological: PepCan Sponsor: University of Arkansas Not yet recruiting |
NUTRI-HAB - Posttreatment Rehabilitation of Nutrition Impact Symptoms in Head and Neck Cancer Survivors Condition: Head and Neck Cancer Intervention: Other: NUTRI-HAB Sponsors: Odense University Hospital; REHPA The Danish Knowledge Centre for rehabilitation and Palliative Care; University of Southern Denmark; University College Copenhagen; Odense Patient Data Explorative Network; Rigshospitalet, Denmark Enrolling by invitation |
Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study Condition: Head and Neck Cancer Intervention: Sponsor: University Health Network, Toronto Recruiting |
A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer Condition: Head and Neck Cancer Interventions: Drug: BMX-001; Radiation: Radiation Therapy; Drug: Cisplatin Sponsors: BioMimetix JV, LLC; Duke University Recruiting |
Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer Condition: Head and Neck Cancer Intervention: Drug: 99mTc-EC-DG Sponsor: University of Chicago Completed |
Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients Condition: Head and Neck Cancer Interventions: Behavioral: Quality of Life Survey; Behavioral: Health Management Surveys; Other: Monitoring Devices; Behavioral: Symptoms Surveys; Behavioral: Device Usability Survey Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Active, not recruiting |
Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema Conditions: Head and Neck Neoplasms; Head and Neck Lymphedema; Head and Neck Cancer Interventions: Device: Head and neck garments for pneumatic compression device; Drug: NIRFLI with ICG Sponsor: Tactile Medical Completed |
By Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete,Greece,00302841026182,00306932607174
Labels
Monday, April 22, 2019
ClinicalTrials : Head and Neck Neoplasms
Subscribe to:
Post Comments (Atom)
Collaboration request
Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...
-
Media Alarms: Eating Meat Heats the Planet You may have noticed a media theme over recent months linking meat eating with climate change...
-
This is the fourth in a series of posts based upon Jordan Peterson's book Maps of Meaning, published in 1999 after 17 years of researc...
No comments:
Post a Comment